The global coagulation
analyzers/reagents market is expected to reach USD 7.9 billion by
2024, according to a new report by Grand View Research, Inc. Rising
technological advancements in coagulation analyzers are expected to be the most
impact rendering driver for lucrative growth of the market. Automation is the
key development that has occurred in recent years.
The most relevant advancement includes combination of different assay
procedures in single equipment and various commercially available hemostasis
analyzers, which are capable of performing tests such as Prothrombin Time (PT),
Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as
these machines can perform chromogenic and immunologic assays.
Moreover, these systems may have the capacity of holding more samples,
providing faster results, and increasing the efficiency of laboratory workflow.
The advancements in hemostasis analyzers are as follows:
·
Integration of the system with track line
systems and work cells, which may improve the reliability of analysis in terms
of single detection system and preanalytical check for interfering substances
·
Failure pattern sensors, which detect insufficient
sample levels and clots and cap piercing, which enhances safety and sample
integrity
·
Automatic reflex testing, repeat testing, and
redilution
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market
Further key findings from the study suggest:
- Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
- Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
- Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
- Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
- The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
- Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
- For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global Coagulation Analyzers &
Reagents market on the basis of product, technology, test type, end-use and
region.
Product Outlook (Revenue, USD Million, 2013 - 2024)
·
Analyzers
o
Clinical Laboratory Analyzers
o
Point of Care Analyzers
·
Consumables
o
Reagents
o
Stains
Technology Outlook (Revenue, USD Million, 2013 - 2024)
·
Mechanical
·
Electrochemical
·
Optical
o
Photo optical/Chromogenic/Immuno
o
Others/Nephelometric
·
Others
Test Type Outlook (Revenue, USD Million, 2013 - 2024)
·
APTT
·
D-Dimer
·
Fibrinogen
·
Prothrombin
·
Others
End-Use Outlook (Revenue, USD Million, 2013 - 2024)
·
Hospitals
·
Research Institutes
·
Diagnostic Centers
·
Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
For more information visit - http://www.grandviewresearch.com/
No comments:
Post a Comment